Bill
Bill > SB773
OK SB773
OK SB773Pharmacy benefit managers; modifying definitions; prohibiting certain circumstances; requiring nonpayment under providing venue for certain court proceeding; allowing Attorney General to obtain certain information. Effective date.
summary
Introduced
02/03/2025
02/03/2025
In Committee
04/15/2025
04/15/2025
Crossed Over
03/26/2025
03/26/2025
Passed
05/06/2025
05/06/2025
Dead
Vetoed
05/12/2025
05/12/2025
Introduced Session
2025 Regular Session
Bill Summary
An Act ENROLLED SENATE BILL NO. 773 By: Gollihare and Jech of the Senate and Stinson of the House An Act relating to pharmacy benefit managers; amending 36 O.S. 2021, Sections 6960, as last amended by Section 1, Chapter 306, O.S.L. 2024, 6962, as last amended by Section 2, Chapter 306, O.S.L. 2024, 6965, as last amended by Section 3, Chapter 306, O.S.L. 2024, and Section 3, Chapter 38, O.S.L. 2022, as last amended by Section 4, Chapter 306, O.S.L. 2024 (36 O.S. Supp. 2024, Sections 6960, 6962, 6965, and 6966.1), which relate to definitions, compliance review, and power, authority to investigate, examine, and enforce, and violations, penalties, and hearings; modifying definitions; prohibiting certain circumstances; requiring nonpayment under providing venue for certain court proceeding; allowing Attorney General to obtain certain information; extending certain duties; allowing certain request for a court reporter; requiring certain refund of certain costs by Attorney General; establishing certain fines and penalties; updating statutory references; and providing an effective date. SUBJECT: Pharmacy benefit manager payments
AI Summary
This bill modifies Oklahoma's laws governing pharmacy benefit managers (PBMs), expanding regulatory oversight and implementing new restrictions on their practices. The bill updates definitions of key terms, prohibits PBMs from engaging in certain unfair practices such as charging enrollment fees to pharmacies, spread pricing, and discriminatory reimbursement policies, and grants the Attorney General broader investigative powers. Specifically, the Attorney General can now request detailed information about prescription drug transactions, subpoena records, and levy fines up to $10,000 per violation. The bill also establishes new requirements for PBMs, including mandatory quarterly reporting of rebate and payment information, maintenance of network development documentation, and full disclosure of pharmaceutical contract details. Additionally, the legislation provides mechanisms for the Attorney General to suspend or revoke a PBM's license for non-compliance, requires PBMs to cooperate with investigations, and establishes specific procedures for hearings and appeals. The bill aims to increase transparency in pharmacy benefit management, protect pharmacies and patients from potentially predatory practices, and provide stronger state-level oversight of PBM operations. The changes will take effect on November 1, 2025.
Committee Categories
Business and Industry, Health and Social Services
Sponsors (3)
Last Action
Veto override message received (on 05/29/2025)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...